-
Down's syndrome screening with nuchal translucency.
Nicolaides KH, Sebire NJ, Snijders RJ.
Lancet 1997;349:438. -
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH.
BJOG 1996;103:999-1003. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3. -
Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
Noble PL, Abraha HD, Snijders RJ, Sherwood R, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:390-5. -
First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
Hyett JA, Moscoso G, Nicolaides KH.
Am J Obstet Gynecol 1995;172:1411-3. -
Increased nuchal translucency in Trisomy 21 fetuses: Relation to narrowing of the aortic isthmus.
Hyett JA, Moscoso G, Nicolaides KH.
Hum Reprod 1995;10:3049-3051. -
Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization.
Hecher K, Snijders R, Campbell S, Nicolaides KH.
Obstet Gynecol 1995;85:122-8. -
Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome.
Brizot ML, Jauniaux E, Mckie AT, Farzaneh F, Nicolaides KH.
Hum Reprod 1995;10:2506-9. -
Serum ferritin and cobalamin in red blood cell isoimmunisation.
Abbas A, Nicolaides KH.
Fetal Diagn Ther 1995;10:297-300.